TrialDiabetes, obesity & metabolism2021

Effect of the glucagon-like peptide-1 analogue liraglutide versus placebo treatment on circulating proglucagon-derived peptides that mediate improvements in body weight, insulin secretion and action: A randomized controlled trial.

Sun H Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.